It has been nearly a century since Benjamin Graham first laid out the principles of value investing, and the strategy remains a cornerstone for those seeking long-term returns by buying companies at a discount to their intrinsic worth. The core idea is deceptively simple: find companies whose market price is lower than their calculated intrinsic value, built on the premise that markets overreact to bad news and underappreciate steady, unglamorous businesses. The key to avoiding a 'value trap' is to ensure that the low valuation is not a mirage caused by deteriorating fundamentals. Therefore, a disciplined value approach requires more than just a cheap price-to-earnings ratio; it demands a holistic check of profitability, financial health, and reasonable growth prospects.
One stock that currently fits this profile is MAXIMUS INC (NYSE:MMS). As a provider of government health and human services programs, it operates in a relatively defensive niche. After a significant pullback in its share price, the company now presents a strong case for value investors, scoring a solid overall fundamental rating of 7 out of 10 according to ChartMill’s analysis, which is detailed in the full fundamental report. The stock was surfaced via a 'Decent Value' screen, which filters for companies that combine a high valuation rating with adequate scores in profitability, health, and growth—precisely the combination that can signal a genuine undervaluation rather than a trap.
Valuation Metrics: The Cheap Price Check
The most striking aspect of MAXIMUS from a value perspective is its valuation rating of 9 out of 10, putting it among the cheapest in the market. The numbers confirm this emphatically:
- Price/Earnings Ratio: The stock trades at a P/E of 8.58, which is not only incredibly low compared to the S&P 500 average of 27.47 but also makes it cheaper than 85.23% of its industry peers.
- Forward P/E: Looking ahead, the valuation looks even more attractive. With a Forward P/E of 7.12, MAXIMUS is priced for very little future growth. This is significantly cheaper than the industry average forward P/E of 44.43.
- Compensation for Growth: The PEG ratio (Price/Earnings divided by Growth) is also low, suggesting that investors are not paying a premium for the company’s expected earnings increases. This is a critical check for value investors, confirming that the stock isn’t just cheap because its growth prospects are broken.
For a value investor, these metrics are the primary signal. The wide gap between the current market price and the earnings power of the business is what Graham called the 'margin of safety,' providing a buffer against unforeseen negative events.
Profitability: Quality Beneath the Price
A low valuation is meaningless if the company cannot generate profits or has poor margins. Fortunately, MAXIMUS scores a solid 8 out of 10 for profitability, which provides the necessary confidence that the business is fundamentally sound.
- Returns on Capital: The company performs well at generating returns. Its Return on Equity (ROE) stands at 21.62%, outperforming 85.23% of competitors. The Return on Invested Capital (ROIC) is 12.02%, also among the best in the industry.
- Trend: Importantly, the current ROIC of 12.02% is higher than its 3-year average of 10.34%, indicating that profitability is improving rather than eroding—a strong sign for value investors who need to see that the business is getting better, not worse.
- Margins: With an operating margin of 10.94% and a profit margin of 6.92%, the company’s operations are efficient and profitable.
This profitability is the foundation of value investing. It proves that the low stock price is not a result of a broken business model, but likely a temporary market sentiment issue.
Financial Health: Stability and Resilience
Value investing is a long-term game, requiring a company to survive economic downturns. MAXIMUS holds a 6 out of 10 rating for health, which is decent but has some nuances.
- Liquidity: The company is very liquid, with a Current Ratio of 2.34 and a Quick Ratio of 2.34, both well above the 1.0 threshold that signals safety. This means it can easily cover its short-term obligations.
- Solvency: The Altman-Z score of 3.20 places it comfortably in the 'safe zone,' well above the 1.8 threshold that indicates bankruptcy risk.
- The Caveat: The main concern is its debt level. While the Debt-to-Equity ratio of 0.88 is manageable, the Debt-to-Free Cash Flow ratio of 7.17 suggests it would take many years to pay off debt using free cash flow. However, this is partially offset by a strong interest coverage ratio implied by its profitability.
For a value investor, the strong liquidity and solvency metrics are reassuring. The moderate debt level is a point to watch, but likely not a deal breaker for a company with stable government contracts.
Growth: The Catalyst for Revaluation
While value stocks are often out of favor due to low growth, MAXIMUS offers a reasonable growth narrative that could act as the catalyst for the stock to re-price higher. The company scores a 5 out of 10 for growth, but the details matter.
- Past Performance: The company grew its Earnings Per Share (EPS) by an impressive 64.30% over the past year, with a long-term average annual growth rate of 13.77%.
- Future Expectations: Analysts expect EPS to grow by 19.19% per annum in the coming years. This is crucial because it justifies the low Forward P/E—if earnings grow by 19%, the stock will look even cheaper a year from now.
- The Risk: The only negative is a slight decline in revenue of -0.15% in the last year, and revenue growth is expected to slow to 2.05% annually. This suggests the growth in earnings is coming from margin expansion and cost efficiency rather than top-line expansion.
Ultimately, the combination of a 9/10 Valuation and a 5/10 Growth rating is a sweet spot for value investors. It suggests the market is pricing in too much pessimism, failing to recognize the company's ability to generate cash and grow earnings.
Analyst Views and Market Context
The general market context is supportive for stocks like MAXIMUS. The S&P 500’s long-term and short-term trends are both positive, suggesting a risk-on environment where undervalued stocks can catch up. While individual analyst ratings are not detailed here, the fundamental data is strong enough to provide a clear investment thesis: a profitable, healthy company growing its earnings significantly is trading at a P/E ratio of just 8.58. This is the textbook definition of a value opportunity.
Finding More Opportunities
This analysis demonstrates that value is still very much alive in the market. By screening for stocks that combine a high valuation rating with decent profitability, health, and growth, investors can uncover companies that are cheap for the right reasons. To explore other stocks that pass this same rigorous screen, you can view the full list and adjust the filters yourself via the dedicated screening link: Discover more 'Decent Value' stocks.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Stock market investments carry risk, and past performance is not indicative of future results. You should consult with a qualified financial advisor before making any investment decisions.